All rights reserved Copyright 2020 Sofwave TM
All rights reserved Copyright 2020 Sofwave TM
News category:
June 6, 2021
Sofwave™ Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange
The Medical Aesthetic company which developed an innovative approach to wrinkle reduction raises $50 million in an initial public offering. TUSTIN, Calif., June 3, 2021 /PRNewswire/ -- On Wednesday, May 26, 2021, Sofwave™ Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE). Sofwave's™, rapid market adoption enabled the listing on the Tel Aviv Stock Exchange.  The company managed to raise $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. SofwaveTM is an emerging leader of energy-based non-invasive skin treatment aesthetic medical devices. The company is one of the only companies in the field of aesthetic medicine that is listed on
Read more
April 20, 2021
Sofwave Receives Australian Regulatory Approval to Market SUPERB™, the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles
It is time to position your aesthetic practice at the forefront of innovation! YOQNEAM, Israel, March 10, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received approval from Australia's Therapeutic Goods Administration (TGA) for its next-generation Sofwave system. Aesthetic practices adding Sofwave to their service menu will be able to offer a noticeable wrinkle reduction in a single treatment through the industry's most innovative energy-based treatment. Dr. Ruthie Amir, Chief Medical Officer at Sofwave, said, "this revolutionary single-treatment wrinkle reduction technology continues to be enthusiastically received by physicians and consumers in North America, and we are
Read more
March 2, 2021
Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada
Sofwave is crucial to your aesthetic practice. Learn Why! YOQNEAM, Israel, Feb. 24, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance from Health Canada for its next-generation Sofwave system. Aesthetic practices adding Sofwave to their service menu will be able to offer a noticeable wrinkle reduction in a single treatment through the industry's most innovative energy-based treatment. According to Sharyn A Laughlin M.D., a leading expert in the field of dermatology and Medical Director of Laserderm, this new device meets an unmet need. "  "Using Sofwave I can give my
Read more
X